transplantation (uBMT) and that the occurrence of cGVHD could result in good prognosis. (ASH 2007;110;5092). Here, we analyzed the clinical picture of ...
.F 1
ht
st er Ba
te d
yr ig
d. F1
yr ig
ht
Ba
Clinical characteristics and GVL effects of chronic GVHD following reduced-intensity cord blood transplantation (RICBT)
ht p
yr ig
C
Other Variables:
d. F1 0 1500 days
uBMT/RIST significantly.
2500
2000
■ Mainly consist of limited type and quiescent type on classic definition,
0.017
0.789 (0.466-1.339)
0.381
nk .C op
Other Variables:
■ Treatment period was shorter than that of uBMT/RIST.
■ The possibility to require more than 0.5mg/kg dose of systemic
Sex, Diseases type (myeloid vs lymphoid), PS, HCT-CI, GVHD prophylaxis, Preparative regimen, TBI, TNC, CD34+ cell doses, Major MM, PIR, aGVHD
■ High KPS score following RICBT suggests high quality of life (QOL) .
Survival (survivors beyond 100 days after transplantation ) PFS
